{"id":77084,"date":"2026-02-04T12:04:04","date_gmt":"2026-02-04T12:04:04","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/"},"modified":"2026-02-04T12:04:04","modified_gmt":"2026-02-04T12:04:04","slug":"c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","title":{"rendered":"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026"},"content":{"rendered":"<div>\n<p>WATERTOWN, Mass., Feb.  04, 2026  (GLOBE NEWSWIRE) &#8212; C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 taking place from February 11 \u2013 12, 2026 in New York, NY.<\/p>\n<p><strong>Fireside Chat Details:<\/strong><br \/><strong>Date:<\/strong> Wednesday, February 11, 2026 <br \/><strong>Time:<\/strong> 11:30 AM ET<\/p>\n<p>A live webcast will be available on the Investors section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FClJa2UXZZQjOfcVKrpRKNzzSvXJ_MvSjZOj59j34_a1yhZRy3eKUxI9wWFBs1YadSdyWxCB63ysvehr0txy1VfQzBclICr-M90rBUHzjAs=\" rel=\"nofollow\" target=\"_blank\" title=\"www.c4therapeutics.com\">www.c4therapeutics.com<\/a>. An archived replay of the webcast will be available for approximately 90 days following the event.<\/p>\n<p><strong>About C4 Therapeutics<\/strong><br \/>C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients\u2019 lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO<sup>\u00ae<\/sup>\u00a0platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T\u2019s degrader medicines are designed to harness the body\u2019s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FClJa2UXZZQjOfcVKrpRKNzzSvXJ_MvSjZOj59j34_Y6Rk2gtHRmCRBP_A_WeZ0gp0eMptz8OGpbys7w2yVP5VQ3PjIzriNFw2DQ5TVY0D2orHM7064QTDaviZAyD0JPtu_OerCobnfNYx0O8bZqYLJ9eE82SZ041BbhIaXOPHEOfQO-tzKekD6_D__udDEFq3hnMzcc6ecMaL69ipxpaKWfoPjeUSF94GCCaxHW2wdbrd8G31EW9IIpu-TN5agBU9gFOZuycLmBI6KOwx1E65eekJebahYmJUGYrElKI5BP5-I6yDr9R040r-fWGE9oGLZehwh4flNVhpfRf0GPYrz2HPjkRx7nMwu6CZxSjxHZ95JW27g3povoKaAUH9xBWo2pk4AVLiZYw3mWVN4BV4J-GzJumOW5nJy9zoD-sH9D42Z-9JbClPoGf5m4ACtHn8ZBW2A2R03WXt4KRCvUcXmk4gaH5o8zI6VdhyZnetBcGNQqJ4xjIry28K56PjgMI_NX7HslWyfWopIjnFO34zq-vdNzKTQyGoXatBqikQr9yc-edwd2nJrmlxm5aqQXwmG3va6RAv5HqOvBCMca90UIZ5NRj-JWdLCMHH9NkwadMf83ECVKokBUmMsZvVOUVyVykS6rdcsUxqoNuzlsb59FyRkrftu_cmhvqbF3vA3Pwd1WqxK4SOiJWSx9ySFUW2_2OCcQp_-U5_U8XXGRzTkKTS88Kevaffc4YeM37Pr-i-uQTJkCad3QCtFwWRThtY37TDlpCVVCMM00UGagcsZrKYkyiee0viV7430BNZE=\" rel=\"nofollow\" target=\"_blank\" title=\"www.c4therapeutics.com\">www.c4therapeutics.com<\/a>.<\/p>\n<p><strong>Contacts:<\/strong><br \/>Investors:<br \/>Courtney Solberg<br \/>Associate Director, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l00ItOSJ3mGaAbOjBhE9qbj770a_Q_GemH2yoD3tkH22XTlqEBjcubvWPW3XduTMe0GWs4jFH4aItsi2TSxZeypw1wz-FtOh4tSf94DDTbGcLxqWNhfVVeGjs9T1wUj9M7twoMgvcoGSX1uIbDMwRKtkLDu6W5U2NsGaFVmrgElTiqXGxa6cn8SrY8mnaCyTrXFwWsIe9mXXzCqzLtsz7D3VAvU1WRbP4fbVEwMZ02MFLUFdhDVNsPpraTzUOU8JU9roIXxRNiNJ7u7ylW64mORWWo8k0YHGI4ciLLD0BBuqHzwMdnH34UYCQqeGS27ZOTzetbI94Mb2xBXz1tIgaXs4zFXO1C6j2aAdyqwYMlb_ToW_dC03xnWYNImtnhkNBoZpzjhvLDmUuUkrp1cS3hbiJgpFflxoHo4pOGfqF7wiyhLi79JWsgzjne5UGOzuGf-H5OxBtQNRsDjAyDqcEc49MpJaYfMT69i0AbZlsB_zA41FvvriVTZ2EnxrL5sZicEt2oEb-SWbdQbb9eK3y6RzmyTi6g8uOTnI-M-ZiZJSzdwH5j11ThN4P1XilQQ2\" rel=\"nofollow\" target=\"_blank\" title=\"CSolberg@c4therapeutics.com\">CSolberg@c4therapeutics.com<\/a><\/p>\n<p>Media:<br \/>Loraine Spreen<br \/>Senior Director, Corporate Communications &amp; Patient Advocacy<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4Y10ahXvoSr5ZaD8cqWiwyz4_9zyeilQEp5zFGDTlofHfoGiIiaKbTiVkT7M8pIB2wWzOjNVQRt0TOhDThc2oGZMqC1uFfc4gGbCCC_UBoBM-vf0cgpDJ0o4mg4MRr0RIuxTdwxi_GharwdkQqX9GCRFVev3oo1T7Bswpbx9GaZ9-2fqSJa4gMN7YzGrylDini681MdVgHyxjKg-d0pXTN9JsAKCSLb0TtUFzAZ4deKVpxPi_eNekGrHv85mjq7sj1CHdEi5l4u0pbdTARcgQNbfLUciirCOfXW5GW-0ZG0OamZjFk0vpPr9cPV4SrTLFgR0psee6YfpxAYk0rBr1lsyE2aj80DE-tHsxyTDBKL2YD0mmHMc3eVkLqF7at1bR6o6zvDviLy93zpq3yv7WjsqeZSrL_rK9XzKdMAw5iO7WpUTFnMVt-3AS0ToI_lIRs9rzYU0so5F4qabrEGwSa2lMhtnS-2ZUdapk81nGJs-5wbPFrMMfx0c3YX73Fn1_2sdWC3C5vxL_fkFxtpl-Q==\" rel=\"nofollow\" target=\"_blank\" title=\"LSpreen@c4therapeutics.com\">LSpreen@c4therapeutics.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDc1MmExNWQtNDhlMy00ZTAxLTkxNzUtNjVjMTI5OGYyNDFlLTEyMTE5NDAtMjAyNi0wMi0wNC1lbg==\/tiny\/C4-Therapeutics-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) &#8212; C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 taking place from February 11 \u2013 12, 2026 in New [&#8230;]\n","protected":false},"author":1,"featured_media":77085,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-77084","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) &#8212; C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-04T12:04:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/02\/C4-Therapeutics-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026\",\"datePublished\":\"2026-02-04T12:04:04+00:00\",\"dateModified\":\"2026-02-04T12:04:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\"},\"wordCount\":237,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\",\"name\":\"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-02-04T12:04:04+00:00\",\"dateModified\":\"2026-02-04T12:04:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","og_locale":"en_US","og_type":"article","og_title":"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026","og_description":"WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) &#8212; C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedica","og_url":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-02-04T12:04:04+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/02\/C4-Therapeutics-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026","datePublished":"2026-02-04T12:04:04+00:00","dateModified":"2026-02-04T12:04:04+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/"},"wordCount":237,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","url":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","name":"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-02-04T12:04:04+00:00","dateModified":"2026-02-04T12:04:04+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/c4-therapeutics-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/77084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=77084"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/77084\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/77085"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=77084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=77084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=77084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}